Nipocalimab (Anti-FcRn) (FCGRT & B2M)

Ask supplier a question | View on supplier's website

Nipocalimab (anti-FcRn) (FCGRT & B2M) is a fully human monoclonal antibody that targets the neonatal crystallizable fragment receptor (FcRn) with potential immunomodulating activity. MW: 142.12 KD.

Supplier	Selleck Chemicals
Product #	A2948
Sku #	A2948-1mg*25
Pricing	1mg*25, $2970.00

Feedback